← Back to all trials
Not Yet Recruiting
NCT05714800
Endocardial Mapping of Left Atrium for Evaluation of Concomitant Surgical Ablation Lesions
Conditions: Atrial Fibrillation
Sex: All
Ages: 18 Years – 80 Years
Enrollment: 50
Sponsor: University Medical Centre Ljubljana
Summary
Concomitant ablation is an effective treatment for patients with various types of atrial fibrillation undergoing heart surgery.However, recurrences of tachycardias after concomitant ablation can happen and seem to be mostly related to reentry mechanism resulting in atrial tachycardias.The aim of the study is to perform invasive re-mapping of ablated regions in the atria to assess durability of ablation lesions and prevalence of conduction gaps that can be targets for additional ablation to lower longterm arrhythmia recurrence.
Eligibility Criteria
Inclusion Criteria:all patients scheduled for any kind of elective heart surgery having also indication (EHRA and/or HRS guidelines) to undergo concomitant ablation for any type of atrial fibrillationExclusion Criteria:life expectancy of less than one year,severe heart failure with left ventricular ejection fraction below 35%,emergency surgery due to a life threatening condition such as acute aortic dissection, papillary muscle rupture, acute endocarditis, major trauma,...
Source: ClinicalTrials.gov (NCT05714800). StuddyBuddy aggregates publicly available trial information.